Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain AXGN message board posts where the ticker symbol AXGN has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest AXGN SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001179110-18-007135 Size: 4 KB
2018-05-18
8-K  Documents Current report, items 5.02, 5.03, 5.07, and 9.01
Acc-no: 0001558370-18-004884 (34 Act)  Size: 267 KB
2018-05-18 001-36046
18847437
8-K  Documents Current report, items 1.01, 8.01, and 9.01
Acc-no: 0001104659-18-032939 (34 Act)  Size: 362 KB
2018-05-14 001-36046
18830673
424B5  Documents Prospectus [Rule 424(b)(5)]
Acc-no: 0001047469-18-003636 (33 Act)  Size: 459 KB
2018-05-10 333-224713
18820261
424B5  Documents Prospectus [Rule 424(b)(5)]
Acc-no: 0001047469-18-003546 (33 Act)  Size: 454 KB
2018-05-07 333-224713
18812322
S-3ASR  Documents Automatic shelf registration statement of securities of well-known seasoned issuers
Acc-no: 0001047469-18-003538 (33 Act)  Size: 185 KB
2018-05-07 333-224713
18811235
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001558370-18-003532 (34 Act)  Size: 3 MB
2018-04-30 001-36046
18790136
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001558370-18-003529 (34 Act)  Size: 314 KB
2018-04-30 001-36046
18789972
8-K  Documents Current report, items 1.01 and 9.01
Acc-no: 0001558370-18-002975 (34 Act)  Size: 95 KB
2018-04-13 001-36046
18754497
DEFA14A  Documents Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Acc-no: 0001558370-18-002664 (34 Act)  Size: 29 KB
2018-03-30 001-36046
18726622
More AXGN SEC Filings


Related news from
Wed, 23 May 2018
11:00:00 +0000
AxoGen, Inc. to Present at the Jefferies Global Healthcare Conference
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Karen Zaderej, president and CEO, will present at the Jefferies Global Healthcare Conference in New York City. AxoGen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body.
Mon, 21 May 2018
11:01:00 +0000
AxoGen, Inc. Announces Appointment of Karen Zaderej as Chairman of the Board
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that its Board of Directors has elected Karen Zaderej as Chairman of the Board in addition to her current role as President and Chief Executive Officer (CEO), effective immediately. Zaderej succeeds Jamie M. Grooms, who will remain a Director of the Board. “As the founder of AxoGen, it has been a tremendous privilege to initiate and develop truly revolutionary products that improve quality of life for patients with peripheral nerve damage,” stated Jamie Grooms.
Mon, 14 May 2018
11:00:00 +0000
AxoGen, Inc. Announces Closing of Public Offering of Common Stock
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced the closing of its previously announced underwritten public offering of 3,450,000 shares of its common stock, at a price to the public of $41.00 per share. The number of shares sold by AxoGen includes an aggregate of 450,000 shares of common stock offered and sold pursuant to an option granted to the underwriters that was exercised in full. The total net proceeds from the offering for AxoGen are estimated to be approximately $132,463,000, after deducting underwriting discounts and commissions and other estimated offering expenses payable by AxoGen.
Wed, 09 May 2018
11:00:00 +0000
AxoGen, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced today that it has priced an underwritten public offering of 3,000,000 shares of its common stock, which was upsized from the previously announced 2,000,000 shares, at a price of $41.00 per share, resulting in gross proceeds (before underwriting discounts and offering expenses) to the Company of approximately $123,000,000. In addition, AxoGen has granted the underwriters a 30-day option to purchase up to an aggregate of 450,000 shares of common stock at the same price. AxoGen intends to use the net proceeds from the proposed offering for long term facility and capacity expansion and general corporate purposes.
Mon, 07 May 2018
20:04:00 +0000
AxoGen Announces Proposed Public Offering of Common Stock
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced today that it has commenced an underwritten public offering of 2,000,000 shares of its common stock. In addition, AxoGen expects to grant the underwriters a 30-day option to purchase up to an aggregate of an additional 300,000 shares of common stock sold in connection with the offering at the public offering price. AxoGen intends to use the net proceeds from the proposed offering for long term facility and capacity expansion and general corporate purposes.
Wed, 02 May 2018
08:31:39 +0000
Edited Transcript of AXGN earnings conference call or presentation 30-Apr-18 8:30pm GMT
Q1 2018 AxoGen Inc Earnings Call
Mon, 30 Apr 2018
21:31:26 +0000
AxoGen: 1Q Earnings Snapshot
The Alachua, Florida-based company said it had a loss of 16 cents per share. Losses, adjusted for non-recurring costs, were 11 cents per share. The results met Wall Street expectations. The average estimate ...
Mon, 30 Apr 2018
20:05:00 +0000
AxoGen, Inc. Reports 2018 First Quarter Financial Results
ALACHUA, Fla., April 30, 2018-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today reported financial results and business highlights for ...
Mon, 30 Apr 2018
16:30:00 +0000
AxoGen, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / April 30, 2018 / AxoGen, Inc. (NASDAQ: AXGN ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 30, 2018 at 4:30 PM Eastern Time. To listen ...
Wed, 18 Apr 2018
11:00:00 +0000
AxoGen, Inc. to Report First Quarter 2018 Financial Results and Host Conference Call on April 30, 2018
AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that it will report first quarter 2018 financial results on Monday, April 30, 2018 after the market closes. AxoGen management will host an investment-community conference call and webcast following the release at 4:30 p.m. ET to discuss the financial results and provide a corporate update. Investors interested in participating in the conference call by phone may do so by dialing toll free at (877) 407-0993 or use the direct dial-in number at (201) 689-8795. Those interested in listening to the conference call live via the Internet may do so by visiting the Investors page of the company's website at www.axogeninc.com and clicking on the webcast link.
Thu, 12 Apr 2018
11:00:00 +0000
AxoGen, Inc. Announces 2018 Annual Shareholders’ Meeting
Monday, May 14, 2018 at 4:00 p.m. Eastern Time Hyatt Regency Orlando International Airport. ALACHUA, Fla., April 12, 2018-- AxoGen, Inc., a global leader in developing and marketing innovative surgical ...
Tue, 10 Apr 2018
11:55:00 +0000
Factors of Influence in 2018, Key Indicators and Opportunity within Randgold Resources, GasLog Partners LP, Mountain Province Diamonds, NEXEO SOLUTIONS, AxoGen, and Silicon Motion Technology — New Research Emphasizes Economic Growth
NEW YORK, April 10, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Tue, 27 Mar 2018
16:22:04 +0000
AxoGen (AXGN) Enters Overbought Territory
AxoGen, Inc. (AXGN) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Fri, 23 Mar 2018
11:30:00 +0000
Biotricity: A Little Known Stock That Could Be The Next AXGN or EXAS
Axogen and Exact Sciences have been big winners in the healthcare sector as they've launched new and attractive products into big addressable markets. Many investors overlooked these opportunities because ...
Wed, 14 Mar 2018
11:55:00 +0000
Research Report Identifies China Tel, Eaton Corporation, Ctrip.com International, AxoGen, Athene Holding, and Intuitive Surgical with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, March 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Wed, 07 Mar 2018
12:20:00 +0000
Blog Exposure - Boston Scientific Acquired EMcision for Undisclosed Amount
Stock Monitor: AxoGen Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 07, 2018 / Active-Investors.com has just released a free research report on Boston Scientific Corp. (NYSE: BSX ). If you want ...
Mon, 05 Mar 2018
16:07:23 +0000
Are Earnings Prospects Improving For Loss-Making AxoGen Inc’s (NASDAQ:AXGN)?
When AxoGen Inc (NASDAQ:AXGN) released its most recent earnings update (31 December 2017), I compared it against two factor: its historical earnings track record, and the performance of its industryRead More...
Fri, 02 Mar 2018
17:32:53 +0000
AxoGen (AXGN) Q4 2017 Earnings Conference Call Transcript
AXGN earnings call for the period ending December 31, 2017.
Fri, 02 Mar 2018
05:11:20 +0000
Edited Transcript of AXGN earnings conference call or presentation 28-Feb-18 9:30pm GMT
Q4 2017 AxoGen Inc Earnings Call
Wed, 28 Feb 2018
22:03:14 +0000
AxoGen reports 4Q loss
On a per-share basis, the Alachua, Florida-based company said it had a loss of 7 cents. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "I joined almost three years ago and have never been sorry. The search features here are terrific." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards